Literature DB >> 792407

Erythromycin: a review of its uses in pediatric practice.

C M Ginsburg, H F Eichenwald.   

Abstract

Erythromycin continues to be a valuable and useful antimicrobial agent in children. Its low index of toxicity, freedom from sensitization, and reliable absorption and when administered orally contribute to make it an attractive agent in the treatment of a variety of minor respiratory and skin infections, especially in those situations where real or potential allergy to penicillin exists. Additional major uses are in the eradication of the carrier state in whooping cough and in diphtheria, especially in those instances when oral therapy can be tolerated. Dispite use over more than two decades, resistance developing in formerly susceptible organisms has not been a problem and thus seems unlikely to become so in the future.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 792407     DOI: 10.1016/s0022-3476(76)80590-2

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  The use of antimicrobial drugs in office practice.

Authors:  M R Achong
Journal:  Can Fam Physician       Date:  1982-12       Impact factor: 3.275

2.  Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.

Authors:  P Patamasucon; S Kaojarern; H Kusmiesz; J D Nelson
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

Review 3.  Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.

Authors:  J Singh; B Burr; D Stringham; A Arrieta
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 4.  Pharmacokinetics of anti-infective agents in paediatric patients.

Authors:  D R Butler; R J Kuhn; M H Chandler
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447

Review 5.  A review of the medical considerations of the use of tylosin and other macrolide antibiotics as additives in animal feeds.

Authors:  H Knothe
Journal:  Infection       Date:  1977       Impact factor: 3.553

6.  Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group.

Authors:  H Scholz; R Noack
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-07       Impact factor: 3.267

7.  Adverse events in people taking macrolide antibiotics versus placebo for any indication.

Authors:  Malene Plejdrup Hansen; Anna M Scott; Amanda McCullough; Sarah Thorning; Jeffrey K Aronson; Elaine M Beller; Paul P Glasziou; Tammy C Hoffmann; Justin Clark; Chris B Del Mar
Journal:  Cochrane Database Syst Rev       Date:  2019-01-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.